Victory Capital Management’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,637
Closed -$669K 2614
2022
Q3
$669K Sell
25,637
-782
-3% -$20.4K ﹤0.01% 1918
2022
Q2
$580K Buy
26,419
+93
+0.4% +$2.04K ﹤0.01% 1980
2022
Q1
$588K Sell
26,326
-4,188
-14% -$93.5K ﹤0.01% 2062
2021
Q4
$1.31M Sell
30,514
-289,145
-90% -$12.4M ﹤0.01% 1710
2021
Q3
$21.3M Buy
319,659
+11,402
+4% +$758K 0.02% 872
2021
Q2
$22.6M Sell
308,257
-78,528
-20% -$5.76M 0.02% 859
2021
Q1
$26.5M Buy
386,785
+26,918
+7% +$1.84M 0.03% 798
2020
Q4
$24.2M Buy
359,867
+340,767
+1,784% +$22.9M 0.03% 799
2020
Q3
$983K Sell
19,100
-3,793
-17% -$195K ﹤0.01% 1710
2020
Q2
$863K Sell
22,893
-22,089
-49% -$833K ﹤0.01% 1800
2020
Q1
$1.34M Buy
44,982
+42,982
+2,149% +$1.28M ﹤0.01% 1748
2019
Q4
$69K Sell
2,000
-702
-26% -$24.2K ﹤0.01% 2595
2019
Q3
$49K Buy
+2,702
New +$49K ﹤0.01% 2691